Filing Details
- Accession Number:
- 0001104659-23-019704
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-13 16:15:31
- Reporting Period:
- 2023-02-10
- Accepted Time:
- 2023-02-13 16:15:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1633070 | Axcella Health Inc. | AXLA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1774663 | Paul Fehlner | C/O Axcella Health Inc. 840 Memorial Drive Cambridge MA 02139 | Svp & Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-10 | 5,221 | $0.66 | 58,081 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales were automatic and intended to qualify under Rule 10b5-1.
- The Reporting Person previous reported a grant of RSUs in Table II of Form 4. The total reported in Column 5 includes 42,500 RSUs previously reported in Table II, net shares sold to cover tax withholding obligations as described above.
Billionaire Hedge Funds
